Watch ADRX. Know when insiders buy.
One email the day a filing lands. Free.
ADRX
ADARx Pharmaceuticals, Inc.
14.20
−0.71 −4.76%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · insiders 100
Insiders, 90 days
+$87.7M
net buying · 13 buys, 0 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 13.23 – 20.64
Who holds it
None of the 15 tracked funds disclose ADRX in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Zhen Li9.7%
Yi Shi and 3 related11.1%
SR One Capital Management, LLC and 9 related9.3%
“The Funds acquired their respective shares for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, the Funds and other Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set…”
ORBIMED ADVISORS LLC and 4 related14.0%
“This Statement on Schedule 13D relates to the acquisition of Shares by the Reporting Persons. The Shares acquired by the Reporting Persons were acquired for the purpose of making an investment in the Issuer and not with the intention of acquiring control of the Issuer's business on behalf of the Rep…”
BCLS Fund III Investments, LP6.3%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.